Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Development
Star Scientific Announces Intent to Pursue Drug Development
July 10th, 2007
Star Scientific, Inc. (NASDAQ: STSI) announced approval by the company's board of directors to reorganize the company's corporate structure to provide for a separation of its core businesses: tobacco manufacturing operations, principally in the area of very low-TSNA dissolvable smokeless tobacco products; and intellectual property and new-product development operations, including pharmaceutical products that use a botanical tobacco component. The long-term objective of this initiative is to position the company so that it can consider spinning off to its shareholders Star Tobacco's operations, which include the manufacturing, distribution and sales of the very low-TSNA dissolvable...
Source: Drug Law Weekly (2007-07-10)
|
|
Advertisement |
|
|
|
